Non-Invasive Remote Monitoring in Heart Failure: Towards Wearable Devices and Artificial Intelligence Solutions : Short Title: Remote Monitoring and Wearable Devices in Heart Failure.
Camila S Pizarro, Bas B S Schots, Mark J Schuuring, Pim van der Harst, René van Es, Marish I F J Oerlemans
{"title":"Non-Invasive Remote Monitoring in Heart Failure: Towards Wearable Devices and Artificial Intelligence Solutions : Short Title: Remote Monitoring and Wearable Devices in Heart Failure.","authors":"Camila S Pizarro, Bas B S Schots, Mark J Schuuring, Pim van der Harst, René van Es, Marish I F J Oerlemans","doi":"10.1007/s11897-025-00725-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>This review examines the potential benefits of non-invasive remote monitoring in patients with heart failure (HF), focusing on early detection of clinical deterioration and reducing hospitalizations. Key questions addressed include: Can remote monitoring prevent hospitalisations in patients with HF? Does it improve quality of life and promote self-care? Is it cost-effective? Can artificial intelligence (AI) facilitate its implementation?</p><p><strong>Recent findings: </strong>Monitoring with non-wearable and wearable devices reduces hospitalizations by detecting early signs of deterioration and enhancing self-care behaviour. While the initial investment can be high, the long-term cost-effectiveness is supported by reduced hospitalisations. AI is increasingly integrated into monitoring systems, enhancing predictive accuracy and personalized care. Remote monitoring reduces mortality and hospitalisations in patients with HF, with benefits in cost-effectiveness, and the potential to optimize care delivery by integrating AI. Future research should focus on identifying monitoring strategies for specific HF populations, such as patients with advanced HF.</p>","PeriodicalId":10830,"journal":{"name":"Current Heart Failure Reports","volume":"22 1","pages":"44"},"PeriodicalIF":3.7000,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12678519/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Heart Failure Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s11897-025-00725-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose of review: This review examines the potential benefits of non-invasive remote monitoring in patients with heart failure (HF), focusing on early detection of clinical deterioration and reducing hospitalizations. Key questions addressed include: Can remote monitoring prevent hospitalisations in patients with HF? Does it improve quality of life and promote self-care? Is it cost-effective? Can artificial intelligence (AI) facilitate its implementation?
Recent findings: Monitoring with non-wearable and wearable devices reduces hospitalizations by detecting early signs of deterioration and enhancing self-care behaviour. While the initial investment can be high, the long-term cost-effectiveness is supported by reduced hospitalisations. AI is increasingly integrated into monitoring systems, enhancing predictive accuracy and personalized care. Remote monitoring reduces mortality and hospitalisations in patients with HF, with benefits in cost-effectiveness, and the potential to optimize care delivery by integrating AI. Future research should focus on identifying monitoring strategies for specific HF populations, such as patients with advanced HF.
期刊介绍:
This journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of heart failure. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as investigative, pharmacologic, and nonpharmacologic therapies, pathophysiology, and prevention. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.